Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ARMEEN MAHVASH and BRUNO CALAZANS ODISIO.
ARMEEN MAHVASH
Connection Strength
2.610
BRUNO CALAZANS ODISIO
  1. Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes. J Gastrointest Surg. 2023 09; 27(9):1867-1875.
    View in: PubMed
    Score: 0.235
  2. A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis. Eur Radiol Exp. 2023 01 30; 7(1):4.
    View in: PubMed
    Score: 0.230
  3. Temporary Reversal of Hepatoenteric Collaterals during 90Y Radioembolization Planning and Administration. Curr Oncol. 2022 Dec 06; 29(12):9582-9592.
    View in: PubMed
    Score: 0.227
  4. A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021; 8:1129-1145.
    View in: PubMed
    Score: 0.209
  5. Involution of Hepatocellular Neoplasm after Embolization of a Portosystemic Vascular Shunt in an Adult with Abernethy Type II Malformation. J Vasc Interv Radiol. 2021 09; 32(9):1391-1393.
    View in: PubMed
    Score: 0.208
  6. Preoperative drainage for perihilar cholangiocarcinoma. Lancet Gastroenterol Hepatol. 2019 01; 4(1):10-11.
    View in: PubMed
    Score: 0.172
  7. Prognostic value of incidental hypervascular micronodules detected on cone-beam computed tomography angiography of patients with liver metastasis. Eur Radiol. 2017 Nov; 27(11):4837-4845.
    View in: PubMed
    Score: 0.154
  8. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Hepatocell Carcinoma. 2016; 3:55-61.
    View in: PubMed
    Score: 0.148
  9. Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatocell Carcinoma. 2016; 3:1-7.
    View in: PubMed
    Score: 0.142
  10. Balloon-Assisted Flow Diversion and Selective Catheterization of Target Vessels for Hepatic Transarterial Embolization. J Vasc Interv Radiol. 2016 Feb; 27(2):283-5.
    View in: PubMed
    Score: 0.141
  11. Why bundled payments could drive innovation: an example from interventional oncology. J Oncol Pract. 2015 Mar; 11(2):e199-205.
    View in: PubMed
    Score: 0.132
  12. Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Rep Radiol. 2013; 2013:560758.
    View in: PubMed
    Score: 0.117
  13. Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy. Curr Oncol. 2022 05 24; 29(6):3825-3848.
    View in: PubMed
    Score: 0.055
  14. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World J Gastroenterol. 2021 Dec 21; 27(47):8166-8181.
    View in: PubMed
    Score: 0.053
  15. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.
    View in: PubMed
    Score: 0.052
  16. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. J Hepatocell Carcinoma. 2020; 7:117-131.
    View in: PubMed
    Score: 0.049
  17. Durability of partial splenic artery embolization on platelet counts for cancer patients with hypersplenism-related thrombocytopenia. Abdom Radiol (NY). 2020 09; 45(9):2886-2894.
    View in: PubMed
    Score: 0.049
  18. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol. 2020 Jul; 30(7):3862-3868.
    View in: PubMed
    Score: 0.047
  19. Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma. J Clin Med. 2018 Apr 14; 7(4).
    View in: PubMed
    Score: 0.041
  20. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology. 2017; 93(4):233-242.
    View in: PubMed
    Score: 0.039
  21. Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis. Cardiovasc Intervent Radiol. 2017 Feb; 40(2):270-276.
    View in: PubMed
    Score: 0.037
  22. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores. Cardiovasc Intervent Radiol. 2017 Feb; 40(2):202-209.
    View in: PubMed
    Score: 0.037
  23. Eradication of Missing Liver Metastases After Fiducial Placement. J Gastrointest Surg. 2016 06; 20(6):1173-8.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.